We are monitoring the impact of COVID-19 on Preimplantation Genetic Testing Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 6672
Share on
Share on

Global Preimplantation Genetic Testing Market Analysis - By Procedure Type (Genetic Diagnosis, Genetic Screening), By Technology (NGS, PCR, FISH, CGH, SNP), By Products & Services (Reagents And Consumables, Instruments, Software And Services), By Application (Structural Chromosomal Abnormalities, Single Gene Disorders, X-Linked Disorders, HLA Typing, Gender Identification), By End User (Fertility Clinics, Hospitals, And Research Laboratories), By Region - Industry Size, Share, Trends, Forecast and Growth | 2019 - 2024

Pulished: February, 2020
ID: 6672
Pages: 175

Preimplantation Genetic Testing Market Size & Growth (2019 - 2024)

The Global Preimplantation Genetic Testing Market is valued at USD xx billion in 2019 and is projected to grow at a Compound Annual Growth Rate (CAGR) of xx % during the forecast period to a net market size of USD xx billion in 2024.

Report Description:

Preimplantation genetic detection is a method that examines the embryos that are created using the process of in vitro fertilization. This facilitates the implantation of only selected fit embryos into the uterus thus making sure that a healthy baby is delivered. This prevents the carrying of genetic disorders into the family generations. The testing is done by a screening process wherein the healthy ones are frozen and stored.

Recent Developments

  • India recently reported its first case of a savior sibling, and a baby conceived to save a sibling suffering from a chronic disease. In this case, Preimplantation genetic testing was used to identify the embryo with the requisite characteristics of human leukocyte antigen (HLA) so that the sibling could donate stem cells from her bone marrow to her brother who is suffering from Thalassaemia Major.
  • Agilent Technologies Inc. today announced the introduction of Agilent OnePGT, a genome-wide, next-generation sequencing (NGS) solution for preimplantation genetic testing (PGT). OnePGT allows parallel detection of multiple monogenic disorders (PGT-M), translocations (PGT-SR), and aneuploidies (PGT-A) on a single biopsy. This is further expected to increase the options couples have when they try preimplantation genetic testing.
  • A new polygenic test has been developed in the USA which can screen embryos based on the intelligence they would possess should they grow to term. Testing for a limited number of diseases via preimplantation genetic testing is currently allowed by law in many countries, but these developments further raise many uncomfortable questions about the potential role of doctors in deciding who should live and which embryo should not be born.

Drivers and Restraints of Market

Due to the hectic, sedentary and non-active modern life, many couples are facing difficulties in conceiving naturally. The increasing pollution and the usage of chemicals in farming and animal husbandry sectors have greatly exacerbated infertility in the millennial generation. Some couples might also have genetic diseases that they might not wish to be passed down to their offsprings. In these cases, embryos that have been fertilized in vitro have the option of being examined to see if they contain any harmful genetic matter or any disease that either of the parents has. This advancement in science has allowed many couples to have children who might have otherwise not tried at all. The increasing occurrence of infertility around the world, growing support from public and private organizations in this field, rising medical facilities catering to patients with fertility issues, advancing technology in the field of genetics, awareness about chromosomal anomalies with growing age of mother are all the factors that can be attributed to the growth of preimplantation genetic testing market.

Ethical concerns regarding the doctors choosing which embryo might become a full-fledged human and which one might not are troubling some people. The increasingly expensive healthcare facilities are making sure the latest advancements in the field of medicine are accessible only to a few. Rising costs and lack of awareness are thus the two main restraints preventing the market from reaching its full potential.

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 – 2024

Segments Analysed

By Procedure Type, By Technology, By Product and Service, By Application, By End User

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Analysed

North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Companies Analysed

Illumina Inc., Yikon Genomics, CooperSurgical, Oxford Gene Technology, Inc., Thermo Fisher Scientific, Inc., Rubicon Genomics, Inc., Agilent Technologies, Inc., Natera, Inc., Abbott Laboratories, PerkinElmer, Inc., and SciGene Corporation.

 

This research report on the Global Preimplantation Genetic Testing Market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2024.

Preimplantation Genetic Testing Market - By Procedure Type

  • Preimplantation Genetic Screening              
  • Preimplantation Genetic Screening              

Preimplantation Genetic Testing Market - By Technology                 

  • Next-Generation Sequencing         
  • Polymerase Chain Reaction             
  • Validation Biomarkers        
  • Fluorescence in Situ Hybridization
  • Comparative Genomic Hybridization           
  • Single-Nucleotide Polymorphism  

Preimplantation Genetic Testing Market - By Product and Service                                

  • Reagents and Consumables            
  • Instruments           
  • Software and Services       

Preimplantation Genetic Testing Market - By Application                 

  • Aneuploidy             
  • Structural Chromosomal Abnormalities      
  • Single Gene Disorders        
  • X-Linked Disorders              
  • HLA Typing              

Preimplantation Genetic Testing Market - By End users                    

  • Maternity Centers & Fertility Clinics             
  • Hospitals, Diagnostic Labs, and Service Providers   
  • Research Laboratories & Academic Institutes      

Regional Analysis

The top two markets in the world for Preimplantation Genetic Testing are North America and Europe. This can be attributed to the high average wage levels and minimal inequality in terms of access to quality healthcare. The market in the Asia Pacific despite being smaller than the top two markets is projected to increase with the highest rate during the forecast period of 2019-2024.

Some of the significant markets operating in the Global Preimplantation Genetic Testing Market profiled in the report are

  1. Illumina Inc.
  2. Yikon Genomics
  3. CooperSurgical
  4. Oxford Gene Technology, Inc.
  5. Thermo Fisher Scientific, Inc.
  6. Rubicon Genomics, Inc.
  7. Agilent Technologies, Inc.
  8. Natera, Inc.
  9. Abbott Laboratories
  10. PerkinElmer, Inc.
  11. SciGene Corporation.

Illumina Inc., a great company, was founded by David Walt, Larry Bock, John Stuelpnagel, Anthony Czarnik and, Mark Chee in the year 1998. The company mainly develops, manufactures and markets integrated systems for the analysis of genetic variation and testing. It was headed by Francis deSouza, who acted as its CEO and President. As of 2017 it had a total of 5,500 employees and reported net revenue of USD 2.752 billion.

Research Report Key Highlights

  • This report gives a brief description of the Preimplantation Genetic Testing Market and provides a glimpse into what would be covered in the full report.
  • Growth, Drivers & Restrictions, Market Segmentation, and Key players are covered in this Report Description.
  • This report description provides a rough estimate of what the complete report contains and the final report can be customized according to the client's needs and specifications.
  • This could be potentially useful for companies operating in biochemical, pharmaceutical, healthcare and other allied industries due to its wide scope and coverage.
  • The complete report if purchased will contain the analysis of various aspects of the industry using Porter’s five forces analysis.

1. Introduction          

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods

                1.4 General Study Assumptions                

2. Research Methodology                    

                2.1 Introduction        

                2.2 Research Phases                      

         2.2.1 Secondary Research           

         2.2.2 Primary Research

         2.2.3 Econometric Modelling

         2.2.4 Expert Validation  

                2.3 Analysis Design  

                2.4 Study Timeline   

3. Overview                

                3.1 Executive Summary                

                3.2 Key Inferences  

                3.3 Epidemiology       

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)             

                4.1 Market Drivers   

                4.2 Market Restraints                    

                4.3 Key Challenges  

                4.4 Current Opportunities in the Market       

5. Market Segmentation

                5.1 Procedure Type 

                             5.1.1 Introduction           

                             5.1.2 Preimplantation Genetic Screening              

          5.1.3 Preimplantation Genetic Screening              

          5.1.4  Y-o-Y Growth Analysis, By Procedure Type              

         5.1.5  Market Attractiveness Analysis, By Procedure Type            

         5.1.6  Market Share Analysis, By Procedure Type              

                5.2 Technology                 

         5.2.1 Introduction           

         5.2.2 Next-Generation Sequencing         

         5.2.3 Polymerase Chain Reaction             

         5.2.4 Validation Biomarkers        

         5.2.5 Fluorescence in Situ Hybridization

         5.2.6 Comparative Genomic Hybridization           

         5.2.7 Single-Nucleotide Polymorphism  

         5.2.8 Y-o-Y Growth Analysis, By Technology        

         5.2.9 Market Attractiveness Analysis, By Technology      

         5.2.10 Market Share Analysis, By Technology     

                5.3 Product and Service         

         5.3.1 Introduction           

         5.3.2 Reagents and Consumables            

         5.3.3 Instruments           

         5.3.4 Software and Services       

         5.3.5 Y-o-Y Growth Analysis, By Product and Service       

         5.3.6  Market Attractiveness Analysis, By Product and Service    

         5.3.7  Market Share Analysis, By Product and Service      

                5.4 Application                 

         5.4.1 Introduction           

         5.4.2 Aneuploidy             

         5.4.3 Structural Chromosomal Abnormalities      

  5.4.3.1 Translocations

  5.4.3.2 Deletions

  5.4.3.3 Duplications

  5.4.3.4 Inversions

         5.4.4 Single Gene Disorders        

         5.4.5 X-Linked Disorders              

         5.4.6 HLA Typing              

         5.4.7 Gender Identification         

         5.4.8 Y-o-Y Growth Analysis, By Application         

         5.4.9  Market Attractiveness Analysis, By Application      

         5.4.10  Market Share Analysis, By Application     

               5.5 End users                    

         5.5.1 Introduction           

         5.5.2 Maternity Centers & Fertility Clinics             

         5.5.3 Hospitals, Diagnostic Labs, and Service Providers   

         5.5.4 Research Laboratories & Academic Institutes          

         5.5.5 Y-o-Y Growth Analysis, By End-users            

         5.5.6  Market Attractiveness Analysis, By End-users         

         5.5.7 Market Share Analysis, By End-users           

6. Geographical Analysis

               6.1 Introduction        

         6.1.1 Regional Trends    

         6.1.2 Impact Analysis     

         6.1.3 Y-o-Y Growth Analysis        

  6.1.3.1 By Geographical Area

  6.1.3.2 By Procedure type

  6.1.3.3 By Technology

  6.1.3.4 By Product and Service

  6.1.3.5 By Application

  6.1.3.6 By End user

        6.1.4  Market Attractiveness Analysis     

  6.1.4.1 By Geographical Area

  6.1.4.2 By Procedure type

  6.1.4.3 By Technology

  6.1.4.4 By Product and Service

  6.1.4.5 By Application

  6.1.4.6 By End-user

       6.1.5  Market Share Analysis      

  6.1.5.1 By Geographical Area

  6.1.5.2 By Procedure type

  6.1.5.3 By Technology

  6.1.5.4 By Product and Service

  6.1.5.5 By Application

  6.1.5.6 By End-user

                6.2 North America   

         6.2.1 Introduction           

         6.2.2 United States         

         6.2.3 Canada     

                6.3 Europe  

         6.3.1 Introduction           

         6.3.2 U.K             

         6.3.3 Spain         

         6.3.4 Germany 

         6.3.5 Italy            

         6.3.6 France       

                6.4 Asia-Pacific                 

         6.4.1 Introduction           

         6.4.2 China         

         6.4.3 India          

         6.4.4 Japan         

         6.4.5 Australia   

         6.4.6 South Korea           

                6.5 Latin America      

         6.5.1 Introduction           

         6.5.2 Brazil          

         6.5.3 Argentina

         6.5.4 Mexico     

         6.5.5 Rest of Latin America          

                6.6 Middle East & Africa        

         6.6.1 Introduction           

         6.6.2 Middle-East            

         6.6.3 Africa         

7. Strategic Analysis                

                7.1 PESTLE analysis  

         7.1.1 Political     

         7.1.2 Economic 

         7.1.3 Social         

         7.1.4 Technological         

         7.1.5 Legal          

         7.1.6 Environmental       

                7.2 Porter’s Five analysis       

         7.2.1 Bargaining Power of Suppliers        

         7.2.2 Bargaining Power of Consumers    

         7.2.3 Threat of New Entrants     

         7.2.4 Threat of Substitute Products and Services              

         7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                 

                8.1 Illumina, Inc.       

         8.1.1 Overview 

         8.1.2 Product Analysis   

         8.1.3 Financial analysis  

         8.1.4 Recent Developments       

         8.1.5 SWOT analysis       

         8.1.6 Analyst View          

                8.2 Thermo Fisher Scientific Inc.        

                8.3 Agilent Technologies, Inc.                    

                8.4 Perkinelmer, Inc.                     

                8.5 Coopersurgical, Inc.         

                8.6 ABBott Laboratories        

                8.7 Natera, Inc.                

                8.8 Rubicon Genomics, Inc.  

9. Competitive Landscape                    

                9.1 Market share analysis     

                9.2 Merger and Acquisition Analysis

                9.3 Agreements, collaborations and Joint Ventures  

                9.4 New Product Launches  

10. Market Outlook and Investment Opportunities                  

Appendix                    

                a) List of Tables                

                b) List of Figures       

 

  • Global and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms by procedure level along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

Request Sample to view List of Tables & Figures

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample